All PlansAdministrativeLow impact
Recall: Quinapril
UPMC Health Plan·Family Medicine, Internal Medicine, Cardiology +1 more·Pharmacy
We identified it
Jun 20, 2026
Summary
Lupin Pharmaceuticals has recalled four lots of Quinapril Tablets due to cancer-causing nitrosamine impurities above acceptable levels. This is a drug safety recall that may affect patients currently prescribed this blood pressure medication.
Action Required
Immediately: Clinical staff should review patient medication lists to identify those taking recalled Quinapril lots from Lupin Pharmaceuticals. Contact affected patients to discuss alternative ACE inhibitor options with prescribing providers. No billing system changes required as this is a drug safety recall.